438 related articles for article (PubMed ID: 28606052)
1. Targeting the Tumor Microenvironment by Intervention in Interleukin-1 Biology.
Voronov E; Apte RN
Curr Pharm Des; 2017; 23(32):4893-4905. PubMed ID: 28606052
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapeutic approaches of IL-1 neutralization in the tumor microenvironment.
Apte RN; Voronov E
J Leukoc Biol; 2017 Aug; 102(2):293-306. PubMed ID: 28522598
[TBL] [Abstract][Full Text] [Related]
3. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions.
Apte RN; Dotan S; Elkabets M; White MR; Reich E; Carmi Y; Song X; Dvozkin T; Krelin Y; Voronov E
Cancer Metastasis Rev; 2006 Sep; 25(3):387-408. PubMed ID: 17043764
[TBL] [Abstract][Full Text] [Related]
4. Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy?
Apte RN; Voronov E
Immunol Rev; 2008 Apr; 222():222-41. PubMed ID: 18364005
[TBL] [Abstract][Full Text] [Related]
5. Unique Versus Redundant Functions of IL-1α and IL-1β in the Tumor Microenvironment.
Voronov E; Dotan S; Krelin Y; Song X; Elkabets M; Carmi Y; Rider P; Idan Cohen ; Romzova M; Kaplanov I; Apte RN
Front Immunol; 2013; 4():177. PubMed ID: 23847618
[TBL] [Abstract][Full Text] [Related]
6. Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions.
Apte RN; Krelin Y; Song X; Dotan S; Recih E; Elkabets M; Carmi Y; Dvorkin T; White RM; Gayvoronsky L; Segal S; Voronov E
Eur J Cancer; 2006 Apr; 42(6):751-9. PubMed ID: 16530403
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1α.
Rider P; Carmi Y; Voronov E; Apte RN
Semin Immunol; 2013 Dec; 25(6):430-8. PubMed ID: 24183701
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors.
Krelin Y; Voronov E; Dotan S; Elkabets M; Reich E; Fogel M; Huszar M; Iwakura Y; Segal S; Dinarello CA; Apte RN
Cancer Res; 2007 Feb; 67(3):1062-71. PubMed ID: 17283139
[TBL] [Abstract][Full Text] [Related]
9. Antitumor and immunotherapeutic effects of activated invasive T lymphoma cells that display short-term interleukin 1alpha expression.
Voronov E; Weinstein Y; Benharroch D; Cagnano E; Ofir R; Dobkin M; White RM; Zoller M; Barak V; Segal S; Apte RN
Cancer Res; 1999 Mar; 59(5):1029-35. PubMed ID: 10070959
[TBL] [Abstract][Full Text] [Related]
10. The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases.
Palomo J; Dietrich D; Martin P; Palmer G; Gabay C
Cytokine; 2015 Nov; 76(1):25-37. PubMed ID: 26185894
[TBL] [Abstract][Full Text] [Related]
11. Host-derived interleukin-1alpha is important in determining the immunogenicity of 3-methylcholantrene tumor cells.
Elkabets M; Krelin Y; Dotan S; Cerwenka A; Porgador A; Lichtenstein RG; White MR; Zoller M; Iwakura Y; Dinarello CA; Voronov E; Apte RN
J Immunol; 2009 Apr; 182(8):4874-81. PubMed ID: 19342666
[TBL] [Abstract][Full Text] [Related]
12. Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis.
Spohn G; Keller I; Beck M; Grest P; Jennings GT; Bachmann MF
Eur J Immunol; 2008 Mar; 38(3):877-87. PubMed ID: 18253928
[TBL] [Abstract][Full Text] [Related]
13. Inflammasome activation and IL-1β target IL-1α for secretion as opposed to surface expression.
Fettelschoss A; Kistowska M; LeibundGut-Landmann S; Beer HD; Johansen P; Senti G; Contassot E; Bachmann MF; French LE; Oxenius A; Kündig TM
Proc Natl Acad Sci U S A; 2011 Nov; 108(44):18055-60. PubMed ID: 22006336
[TBL] [Abstract][Full Text] [Related]
14. Effects of IL-1 molecules on growth patterns of 3-MCA-induced cell lines: an interplay between immunogenicity and invasive potential.
Voronov E; Reich E; Dotan S; Dransh P; Cohen I; Huszar M; Fogel M; Kleinman HK; White RM; Apte RN
J Immunotoxicol; 2010 Mar; 7(1):27-38. PubMed ID: 20001788
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1--a major pleiotropic cytokine in tumor-host interactions.
Apte RN; Voronov E
Semin Cancer Biol; 2002 Aug; 12(4):277-90. PubMed ID: 12147202
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1α as an intracellular alarmin in cancer biology.
Voronov E; Dinarello CA; Apte RN
Semin Immunol; 2018 Aug; 38():3-14. PubMed ID: 30554608
[No Abstract] [Full Text] [Related]
17. IL-1 Signaling in Tumor Microenvironment.
Zhang W; Borcherding N; Kolb R
Adv Exp Med Biol; 2020; 1240():1-23. PubMed ID: 32060884
[TBL] [Abstract][Full Text] [Related]
18. IL-1 in Colon Inflammation, Colon Carcinogenesis and Invasiveness of Colon Cancer.
Voronov E; Apte RN
Cancer Microenviron; 2015 Dec; 8(3):187-200. PubMed ID: 26686225
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factor-1α/interleukin-1β signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment.
Zhang J; Zhang Q; Lou Y; Fu Q; Chen Q; Wei T; Yang J; Tang J; Wang J; Chen Y; Zhang X; Zhang J; Bai X; Liang T
Hepatology; 2018 May; 67(5):1872-1889. PubMed ID: 29171040
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness.
Song X; Voronov E; Dvorkin T; Fima E; Cagnano E; Benharroch D; Shendler Y; Bjorkdahl O; Segal S; Dinarello CA; Apte RN
J Immunol; 2003 Dec; 171(12):6448-56. PubMed ID: 14662844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
